Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Predictive Oncology Inc (NQ: POAI )

0.6771 +0.1070 (+18.77%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 209,070
Open 0.5601
Bid (Size) 0.6711 (2)
Ask (Size) 0.6749 (1)
Prev. Close 0.5701
Today's Range 0.5601 - 0.6823
52wk Range 0.5500 - 4.021
Shares Outstanding 4,063,081
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From Predictive Oncology Inc.
Via GlobeNewswire

Performance

YTD
-80.79%
-80.79%
1 Month
-26.04%
-26.04%
3 Month
-42.13%
-42.13%
6 Month
-41.13%
-41.13%
1 Year
-81.45%
-81.45%

More News

Read More
TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Reports on Study Confirming Long-Term Stability, Viability of Proprietary Tumor Specimen Biobank
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Study Demonstrates Long-Term Stability and Viability of Proprietary Biobank of Primary Tumor Specimens for Pharmaceutical Drug Discovery
From Predictive Oncology Inc.
Via GlobeNewswire
POAI Stock Earnings: Predictive Oncology Reported Results for Q2 2024
Via InvestorPlace
Why Is Predictive Oncology (POAI) Stock Up 70% Today?
Via InvestorPlace
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Q2 2024 Financial Results, Provides Business Update
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
From Predictive Oncology Inc.
Via GlobeNewswire
BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Announces Expansion of Live-Cell Tumor Platform Applications
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
From Predictive Oncology Inc.
Via GlobeNewswire
AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q2 2024 Financial Results, Conference Call
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
From Predictive Oncology Inc.
Via GlobeNewswire
AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Enters into $1.2M Agreement for Exercise of Warrants
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
From Predictive Oncology Inc.
Via GlobeNewswire
Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Predicitive Oncology Stock Is Soaring
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
Via Benzinga
Dow Jumps 200 Points; Honeywell Trims Profit Outlook
Via Benzinga
Topics Stocks
Exposures US Equities
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Expands Its AI/ML Driven Platform to Include Novel Oncology Biomarker Discovery
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
From Predictive Oncology Inc.
Via GlobeNewswire
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
Via InvestorPlace
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
From Predictive Oncology Inc.
Via GlobeNewswire
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Launches Novel Technology to Accelerate Cancer Drug Discovery, Development
Via Investor Brand Network
Topics Animal Testing Artificial Intelligence
Exposures Animal Testing Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.